Modifications in the Anaerob Threshold in Cyclists by Consuming Docosahexaenoic Acid (DHA) (MATCY)

Universidad Católica San Antonio de Murcia

Status: Completed

Conditions: Performance

Treatments: Dietary Supplement: docosahexaenoic acid; Dietary Supplement: Placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT04128449

UCAMCFE-0004

Details and patient eligibility

About

In a double-blind, parallel randomized clinical trial with 38 cyclists in whom the performance improvement was determined after the consumption of docosahexaenoic acid for one month.

Enrollment: 38 patients

Sex: Male

Ages: 18 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Male between 18 and 75 years old.
• Cyclists who train three or four times a week.

Exclusion criteria

• Suffering some type of chronic disease.
• Consume habitually pharmacological treatments that could influence the physiological or biochemical responses to be analyzed in the present work.
• Consumption in the month prior to the start of the study, or during the performance of the same, functional food enriched with omega-3 fatty acids.
• To present during the performance of the stress tests, any of the absolute or relative contraindications dictated by the American College of Sports Medicine (ACSM, 1999) 15 would be duly informed and excluded from the present study.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

38 participants in 2 patient groups, including a placebo group

docosahexaenoic acid

Experimental group

Description:

1,66 grams/24 hours (5 dragees)

Treatment:

Dietary Supplement: docosahexaenoic acid

Placebo

Placebo Comparator group

Description:

sunflower oil (5 dragees)

Treatment:

Dietary Supplement: Placebo